Maravai LifeSciences Holdings, Inc. Stock
Equities
MRVI
US56600D1072
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.250 USD | -6.25% |
|
+13.64% | -58.72% |
| May. 12 | Maravai LifeSciences Q1 Adjusted Loss Widens, Revenue Falls | MT |
| May. 12 | Maravai LifeSciences Holdings, Inc., Q1 2025 Earnings Call, May 12, 2025 |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 324M 286M 268M 242M 449M 27.72B 504M 3.1B 1.21B 12.57B 1.21B 1.19B 46.72B | P/E ratio 2025 * |
-3.57x | P/E ratio 2026 * | -4.23x |
|---|---|---|---|---|---|
| Enterprise value | 293M 259M 242M 219M 407M 25.11B 456M 2.81B 1.1B 11.39B 1.1B 1.08B 42.32B | EV / Sales 2025 * |
1.51x | EV / Sales 2026 * | 1.07x |
| Free-Float |
47.42% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Maravai LifeSciences Holdings, Inc.
More recommendations
More press releases
More news
| 1 day | -6.25% | ||
| 1 week | +9.22% | ||
| Current month | +11.39% | ||
| 1 month | +27.12% | ||
| 3 months | -43.04% | ||
| 6 months | -53.32% | ||
| Current year | -58.72% |
| 1 week | 1.95 |  | 2.42 |
| 1 month | 1.78 | | 2.42 |
| Current year | 1.66 | | 6.21 |
| 1 year | 1.66 | | 11.5 |
| 3 years | 1.66 | | 35.82 |
| 5 years | 1.66 | | 63.55 |
| 10 years | 1.66 | | 63.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Martin
CEO | Chief Executive Officer | 50 | 2022-09-29 |
Kevin Herde
DFI | Director of Finance/CFO | 54 | 2017-04-30 |
Kate Broderick
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Cunningham
BRD | Director/Board Member | 49 | 2016-02-29 |
| Director/Board Member | 47 | 2016-02-29 | |
Susannah Gray
BRD | Director/Board Member | 64 | 2020-10-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.37% | 6 M€ | 0.00% | - | |
| 0.34% | 3 M€ | -2.63% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.25% | +9.22% | -80.16% | -93.30% | 346M | ||
| -1.59% | +6.00% | +11.55% | +7.00% | 10.91B | ||
| -1.31% | -8.78% | +28.32% | -20.36% | 2.82B | ||
| -4.17% | -5.80% | +23.81% | +50.30% | 2.26B | ||
| -2.88% | -2.15% | +153.20% | +17.90% | 1.42B | ||
| +1.28% | +7.46% | +41.20% | -25.15% | 1.04B | ||
| -3.89% | +5.70% | +9.09% | -34.07% | 988M | ||
| -8.12% | -1.96% | -83.04% | -88.63% | 638M | ||
| +0.34% | +11.71% | +10.02% | - | 336M | ||
| +1.20% | -5.45% | - | - | 152M | ||
| Average | -1.87% | +2.95% | +12.67% | -23.29% | 2.09B | |
| Weighted average by Cap. | -1.91% | +3.99% | +21.78% | +0.45% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 195M 172M 161M 145M 270M 16.66B 303M 1.86B 728M 7.56B 730M 715M 28.08B | 216M 190M 178M 161M 299M 18.44B 335M 2.06B 806M 8.37B 808M 792M 31.09B |
| Net income | -86.74M -76.62M -71.65M -64.67M -120M -7.42B -135M -831M -324M -3.37B -325M -319M -12.51B | -82.58M -72.95M -68.22M -61.58M -115M -7.07B -128M -791M -309M -3.2B -310M -303M -11.91B |
| Net Debt | -30.53M -26.97M -25.22M -22.76M -42.33M -2.61B -47.47M -292M -114M -1.18B -115M -112M -4.4B | -93.15M -82.28M -76.94M -69.45M -129M -7.97B -145M -892M -348M -3.62B -349M -342M -13.44B |
More financial data
* Estimated data
Employees
580
Calendar
05:30pm
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-05-21 | 2.250 $ | -6.25% | 2,428,954 |
| 25-05-20 | 2.400 $ | +10.60% | 2,035,050 |
| 25-05-19 | 2.170 $ | +3.33% | 1,807,709 |
| 25-05-16 | 2.100 $ | +7.14% | 1,860,282 |
| 25-05-15 | 1.960 $ | -1.01% | 2,888,503 |
Delayed Quote Nasdaq, May 21, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2.400USD
Average target price
4.700USD
Spread / Average Target
+95.83%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRVI Stock
Select your edition
All financial news and data tailored to specific country editions
